Title page for etd-1110114-000639


[Back to Results | New Search]

URN etd-1110114-000639
Author Chih-Yu Chien
Author's Email Address No Public.
Statistics This thesis had been viewed 5567 times. Download 16 times.
Department Master of Health Care Management, Department of Business Management
Year 2014
Semester 1
Degree Master
Type of Document
Language zh-TW.Big5 Chinese
Title Effects of Helicobacter Pylori Eradication on Health Resource Utilization of Gastritis Patients - A Case Study of A Southern Local Community Hospital
Date of Defense 2014-11-27
Page Count 36
Keyword
  • gastritis
  • eradication
  • health resource utilization
  • Helicobacter pylori
  • Abstract Objective
      Helicobacter pylori (HP) may cause chronic gastritis, atrophic gastritis, peptic ulcer disease (PUD), even gastric cancer. Eradication therapy can not only heal the injured mucosa, but also prevent PUD relapse and reduce the risk of gastric cancer. National Health Insurance paid for eradication therapy of PUD with HP infection, but not the gastritis patients. So far we don’t have available report regarding health resource utility of such patients who receive eradication therapy. The purpose of this study is to figure out the influence of health resource utility of the HP gastritis patients who receive eradication therapy or not.
    Method
      This is a retrospective study. We enrolled the patients who receive upper gastrointestinal endoscopy (PES) which showed gastritis and rapid urease testing positive in a district hospital. We collected these patient’s medical data, whether receiving eradication therapy, or the frequency of outpatient access and PES, payments for digestant one year before and after the diagnosis made, then go to the statistic analysis.
    Result
      After the HP gastritis patients receiving eradication therapy, the frequency of outpatient access and payment of digestant all decreased, while the frequency of PES is the same. If we enroll the fee for eradication therapy, the payment before and after treatment is of no difference. By the way, the patients who did not receive eradication therapy, all items of health resource utility is off no difference before and after follow up.
    Conclusion
      HP gastritis patients who receiving eradication therapy will reduce the frequency of outpatient access, following decreasing of health resource utility, including fee for registration and co-payments of the patients, and fee for physician visit and drug prescription of National Health Insurance. If the National Health Insurance Administration pay for eradication therapy of HP gastritis patients, it wouldn’t increase the expenditure of the drugs at all.
    Advisory Committee
  • LI-YU Chang - chair
  • Yih Jeng - co-chair
  • Ying-Chun Li - advisor
  • Files
  • etd-1110114-000639.pdf
  • Indicate in-campus at 5 year and off-campus access at 5 year.
    Date of Submission 2014-12-11

    [Back to Results | New Search]


    Browse | Search All Available ETDs

    If you have more questions or technical problems, please contact eThesys